Futura Medical PLC Remuneration of Non-Executive Directors and TVR (7603A)

TIDMFUM

RNS Number : 7603A

Futura Medical PLC

02 January 2018

 
     For immediate release       2 January 2018 
 

Futura Medical plc

("Futura" or "the Company")

Remuneration of Non-Executive Directors and Total Voting Rights

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces the issue of 37,320 new ordinary shares of 0.2 pence each in respect of the 2017 remuneration of its Non-Executive Directors.

In accordance with the terms of their service agreements, Non-Executive Directors receive approximately 30 per cent of their remuneration in the Company's ordinary shares. For 2017 these were issued at 57.50 pence per share, being the average closing mid-price of the last 10 trading days of 2016 (as announced via RNS on 10 January 2017).

The 37,320 new ordinary shares shall rank pari passu with the existing issued ordinary shares of the Company and have been issued as follows:

 
     Director                Number of ordinary shares       Total number of ordinary        Percentage of the 
                             issued for 2017                 shares held                     Company's issued share 
                             remuneration                                                    capital 
     John Clarke                    26,290                       198,976                     0.16% 
     Jonathan Freeman               11,030                         63,565                    0.05% 
 

Application has been made to the London Stock Exchange and it is anticipated that trading of the new ordinary shares will commence on AIM at 8:00am on Monday 8 January, 2018.

Immediately following the above issue, the Company will have 120,696,002 ordinary shares in issue. Since the Company currently holds no shares in treasury, the total number of voting rights in the Company is therefore 120,696,002 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

The shares element of the Non-Executive Directors' remuneration for 2018 will be awarded at 25.10 pence per ordinary share, being the average closing mid-price of the last 10 trading days of 2017. The Non-Executive Directors will receive these shares at the end of the 2018 financial year.

Further details are contained within the notifications below, made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014. Full details of Non-Executive Directors' remuneration will be included in the Company's Annual Report & Accounts.

For further information please contact:

 
     Futura Medical plc 
     James Barder, Chief Executive 
      + 44 (0) 1483 685 670 
      [e-mail] 
      www.futuramedical.com 
 
     N+1 Singer (Nominated Adviser and Broker) 
      Aubrey Powell / Liz Yong / Jens Ehrenburg 
      [phone] 
 
     For media enquiries please contact: 
     Buchanan 
     Mark Court / Sophie Wills / Stephanie Watson 
      + 44 (0) 20 7466 5000 
 

Notes to editors:

About Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
     1        Details of the person discharging managerial responsibilities 
               / person closely associated 
-------  ------------------------------------------------------------------------ 
     a)       Name                            John Clarke 
-------  ------------------------------  ---------------------------------------- 
     2        Reason for the notification 
-------  ------------------------------------------------------------------------ 
     a)       Position/status                 Director/ PDMR 
-------  ------------------------------  ---------------------------------------- 
     b)       Initial notification            Initial notification 
               /Amendment 
-------  ------------------------------  ---------------------------------------- 
     3        Details of the issuer, emission allowance market participant, 
               auction platform, auctioneer or auction monitor 
-------  ------------------------------------------------------------------------ 
     a)       Name                            Futura Medical plc 
-------  ------------------------------  ---------------------------------------- 
     b)       LEI                             21380053QLT46UNV2303 
-------  ------------------------------  ---------------------------------------- 
     4        Details of the transaction(s): section to be repeated 
               for (i) each type of instrument; (ii) each type of transaction; 
               (iii) each date; and (iv) each place where transactions 
               have been conducted 
-------  ------------------------------------------------------------------------ 
     a)       Description of the 
               financial instrument,            Ordinary shares of 0.2p each 
               type of instrument 
                                                GB0033278473 
               Identification code 
-------  ------------------------------  ---------------------------------------- 
     b)       Nature of the transaction       Issue of shares 
-------  ------------------------------  ---------------------------------------- 
     c)       Price(s) and volume(s)                Price(s)           Volume(s) 
                                                -----------------  -------------- 
                                                     57.50 pence        26,290 
                                                -----------------  -------------- 
-------  ------------------------------  ---------------------------------------- 
     d)       Aggregated information 
 
               - Aggregated volume              Not applicable 
 
               - Price 
-------  ------------------------------  ---------------------------------------- 
     e)       Date of the transaction         2 January 2018 
-------  ------------------------------  ---------------------------------------- 
     f)       Place of the transaction        Outside of trading venue 
-------  ------------------------------  ---------------------------------------- 
 
 
     1        Details of the person discharging managerial responsibilities 
               / person closely associated 
-------  ------------------------------------------------------------------------ 
     a)       Name                            Jonathan Freeman 
-------  ------------------------------  ---------------------------------------- 
     2        Reason for the notification 
-------  ------------------------------------------------------------------------ 
     a)       Position/status                 Director/ PDMR 
-------  ------------------------------  ---------------------------------------- 
     b)       Initial notification            Initial notification 
               /Amendment 
-------  ------------------------------  ---------------------------------------- 
     3        Details of the issuer, emission allowance market participant, 
               auction platform, auctioneer or auction monitor 
-------  ------------------------------------------------------------------------ 
     a)       Name                            Futura Medical plc 
-------  ------------------------------  ---------------------------------------- 
     b)       LEI                             21380053QLT46UNV2303 
-------  ------------------------------  ---------------------------------------- 
     4        Details of the transaction(s): section to be repeated 
               for (i) each type of instrument; (ii) each type of transaction; 
               (iii) each date; and (iv) each place where transactions 
               have been conducted 
-------  ------------------------------------------------------------------------ 
     a)       Description of the 
               financial instrument,            Ordinary shares of 0.2p each 
               type of instrument 
                                                GB0033278473 
               Identification code 
-------  ------------------------------  ---------------------------------------- 
     b)       Nature of the transaction       Issue of shares 
-------  ------------------------------  ---------------------------------------- 
     c)       Price(s) and volume(s)                Price(s)           Volume(s) 
                                                -----------------  -------------- 
                                                     57.50 pence        11,030 
                                                -----------------  -------------- 
-------  ------------------------------  ---------------------------------------- 
     d)       Aggregated information 
 
               - Aggregated volume              Not applicable 
 
               - Price 
-------  ------------------------------  ---------------------------------------- 
     e)       Date of the transaction         2 January 2018 
-------  ------------------------------  ---------------------------------------- 
     f)       Place of the transaction        Outside of trading venue 
-------  ------------------------------  ---------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCELLFBVFFEBBB

(END) Dow Jones Newswires

January 02, 2018 10:50 ET (15:50 GMT)